Skip to main content
Clinical Trials/IRCT2015021321062N1
IRCT2015021321062N1
Completed
未知

Clinical trial of comparision of 3and 6 months prophylaxis with valganciclovir for prevention of cytomegalovirus(CMV) disease in children with renal transplantation

Iran University of Medical Sciences0 sites86 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Condition 1: renal failure. Condition 2: CMV infection.
Sponsor
Iran University of Medical Sciences
Enrollment
86
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • The children who receive organs from people who are CMV positive; The children are 1\-14 years\-old
  • Exclusion criteria: The use of Thymoglobuline drug; The children who are effected severely by side effects of valganciclovir drug; for example: severe leukopenia or anemia

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
A randomised Phase III trial of 6 months versus 12 months withdrawal of methotrexate in patients with juvenile idiopathic arthritis in clinical remissiojuvenile idiopathic arthritisMedDRA version: 6.1Level: PTClassification code 10059177
EUCTR2005-001086-34-ITISTITUTO GIANNINA GASLINI
Not yet recruiting
Not Applicable
Comparative study of 2 root coverage procedures of teethHealth Condition 1: null- Patients with bilateral maxillary gingival recessions â?¥2mm classified as Millers class 1 in the esthetic zone of the oral cavity with gingival biotype â?¥1mm without any systemic complications
CTRI/2017/12/010795Manipal college of Dental Sciences Mangalore
Active, not recruiting
Phase 1
Therapeutic efficacy comparison of a six-month treatment by itraconazole and nebulised Ambisome® versus treatment by itraconazole alone in non- or mildly- immunocompromised patients with Chronic Pulmonary Aspergillosis: a prospective, randomized, single blind study, (single aspergilloma excluded).MedDRA version: 20.1 Level: LLT Classification code 10022881 Term: Invasive bronchopulmonary aspergillosis System Organ Class: 100000004862Therapeutic area: Body processes [G] - Circulatory and Respiratory Physiological Phenomena [G09]
EUCTR2018-000972-14-FRCHU DE POITIERS224
Completed
Phase 2
Randomized trial of clinical effect of 6 months or 3months Gn-RH agonist (Goserelin acetate 1.8mg) to endometriosis comlicated uterine myoma
JPRN-UMIN000026073Department of Obstetrics and Gynecology Nara Medical University80
Not yet recruiting
Phase 2
Comparing the Effectiveness of Two Bio-Ceramic Sealers in Treating Necrosed Teeth: A 6-Month Study Using CBCT-Advanced Imaging TechnologyHealth Condition 1: K041- Necrosis of pulp
CTRI/2024/07/070005Dr Riddhi Vasa